Novel material composition capable of regulating activity of intestinal flora and preparation method of novel material composition

Abstract

The invention discloses a novel material composition capable of regulating activity of intestinal flora and a preparation method of the novel material composition. The novel material composition consists of the following components in parts by weight: 15-30 parts of strain, 10-20 parts of small molecular organic acid, 1-2 parts of fruit oligose, 1-10 parts of Radix Et Caulis Acanthopanacis Senticosi, 3-10 parts of spirulina, 10-20 parts of roasted malt, 1-2 parts of Phlomis mongolica Turcz., 1-2 parts of Allium schoenoprasum and 3-10 parts of nutlet. The novel material composition capable of regulating the activity of the intestinal flora can regulate the intestinal flora, growth of beneficial bacteria is promoted, growth of harmful bacteria is inhibited, and repeatedly relapsed intestinal diseases such as diarrhea, abdominal pain, abdominal distention, inappetence, nausea, emesis, constipation and the like can be cured. The preparation method is simple and practicable, and is low in preparation cost and suitable for large-scale industrial production.

Description

technical field

[0001] The invention belongs to the field of new material technology development, and in particular relates to a new material composition for regulating the activity of intestinal flora and a preparation method thereof. Background technique

[0002] The intestinal tract contains a large number of beneficial bacteria and harmful bacteria, which coexist together. When the growth of harmful bacteria in the intestinal tract exceeds the growth of beneficial bacteria, intestinal diseases will be caused. Common intestinal diseases include constipation, diarrhea, abdominal pain, bloating, and appetite Sluggishness, nausea, vomiting, etc., are all related to the improper regulation of intestinal flora. The treatment of these diseases generally adopts Shimusheng, Kangbishen, prednisone and other western medicine treatments, which have the advantage of quick effect, but have side effects on the human body, and the disease relapses easily.

[0003] Patent 201610654551.9...